Last reviewed · How we verify
NCT04627610: PEXITY
Recurrence of Dyschezia in Rectal Prolapse, Rectocele and Elytrocele
trial testing Rectal prolapse, rectocele and elytrocele in Rectal Prolapse in 350 participants. Completed in 9 September 2023.
9 March 2023
Quick facts
| Lead sponsor | University Hospital, Grenoble |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 350 |
| Start date | 9 March 2022 |
| Primary completion | 9 March 2023 |
| Estimated completion | 9 September 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Rectal prolapse, rectocele and elytrocele
Conditions studied
- Rectal Prolapse — all drugs for Rectal Prolapse →
Sponsor
University Hospital, Grenoble
Who can join
18 and older, any sex, with Rectal Prolapse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prolapse of the rectum is a pathology that preferentially affects older women with a significant impact on quality of life. A very large number of therapeutic approaches can be proposed (functional treatment, surgical techniques by perineal approach and surgical techniques by anterior approach). D'Hoore and Pennix described Ventral Rectopexy with prosthetic reinforcement which is accepted as a standard of treatment in much of Europe for externalized prolapse but remains maligned in much of the world. Due to the relatively recent appearance of this technique and the great variability in the management methods, the long-term results of Ventral Rectopexy have been little studied. This surgical technique is the preferred approach offered at CHU Grenoble Alpes. Pr Faucheron have internationally recognized experience in surgical grip with a very high patient volume in recent years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04627610
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rectal Prolapse
Currently open trials in the same condition.
- NCT06245577 — Biological Mesh Versus Synthetic Mesh in Interdisciplinary RRP With SCP · NA · active not recruiting
- NCT05918367 — Multicenter Ventral Mesh Rectopexy Registry Collaborative · recruiting
- NCT04169152 — CAES for Internal Hemorrhoids and Rectal Prolapse · recruiting
- NCT03917056 — Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse · NA · recruiting
- NCT04013152 — Clinical Database of Colorectal Robotic Surgery · active not recruiting
Other University Hospital, Grenoble trials
Trials by the same sponsor.
- NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
- NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
- NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
- NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
- NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04627610 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
- Last refreshed: 14 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04627610.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing